The oral route is ideal for digestive health optimization, leaky gut support, and those preferring non-injectable therapy, while injectable forms may be preferred for targeted musculoskeletal injuries requiring higher localized concentrations
Frequently Asked Questions Research References Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (Hsieh et al., J Mol Med, 2017) BPC 157 promotes tendon healing via tendon outgrowth, cell survival and cell migration, FAK and paxillin phosphorylation (Chang et al., J Appl Physiol, 2011) Regeneration or Risk
As mentioned earlier, most MTHFR sufferers are found to have low glutathione
But, it can change based on how bad the deficiency is and what the patient needs
Is Injectable BPC-157 Better for Tendons or Joints